BioNTech

The Turkish Health Ministry's Science Board is currently working on plans as to when a third dose of the Pfizer/BioNTech's vaccine should start to be given to those who have already received two doses of the jab.

A new formulation is likely to be needed by the middle of next year to protect against COVID-19 as it mutates, Uğur Şahin, the chief executive of BioNTech that is behind one of the first mRNA vaccines against the coronavirus, has told the Financial Times.

The Germany-based BioNTech developed the COVID-19 vaccine jointly with the U.S. pharmaceutical company Pfizer.

Sanofi is dropping plans to develop its mRNA Covid-19 vaccine despite positive results in phases 1 and 2 because of Pfizer/BioNTech and Moderna's dominance in the market, the French pharma corporation announced on Tuesday.

In 2022, adapted vaccines according to current variants of the coronavirus are expected to be approved. Currently, the third dose uses vaccines that we have, but a combination is allowed - in the first and second dose of vector vaccine to be given an mRNA vaccine.

Israel is pressing ahead with its aggressive campaign of offering coronavirus boosters to almost anyone over 12 and says its approach was further vindicated by a U.S. decision to give the shots to older patients or those at higher risk.

It will be applied voluntarily to five groups of people

An order for the approval of a third booster dose of the Pfizer vaccine in Bulgaria is expected to be officially issued today. Yesterday, an expert council at the Ministry of Health approved the booster dose.

Ljubljana – The government has approved a donation of 100,620 doses of the Pfizer/BioNTech vaccine against Covid-19 for Bosnia-Herzegovina.

The donation was approved at a correspondence session last night with the Health Ministry announcing the donation is meant as Slovenia’s humanitarian aid to Bosnia-Herzegovina in coping with the pandemic.

The United States has authorized the use of boosters of Pfizer's COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the population, amounting to tens of millions of Americans, are now eligible for a third shot six months after their second.

Prime Minister Florin Citu announced on Wednesday that a decision was made to start administering the third dose, starting with September 28, for all persons who have more than 6 months after the second dose, with any of the Pfizer BioNTech, Moderna and Astra Zeneca vaccines.

Özlem Türeci and Uğur Şahin, the co-founders of BioNTech, and Katalin Kario, who also works at the Germany-based, biotechnology firm has been announced as the recipients of Germany's most prestigious medicine prize for their mRNA vaccine work.

They will receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2022 on March 14.